The in vitro metabolic activation of the 11-trifluoromethyl analogue of the potent carcinogen 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one to mutagens

Gary Boyd, Helmut H Zepik, Lloyd M King, Costas Ioannides, Maurice M Coombs

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

A strongly electronegative, bay-region analogue of the potent carcinogen 15, 16-dihydro-11-methylcyclopenta[a]phenanthren-17-one, namely 15, 16-dihydro-11-trifluoromethylcyclopenta[a]phenanthren-17-one, is mutagenic to Salmonella typhimurium TA100. Also it is metabolized at the 1, 2- and 3, 4-positions in the A-ring as well as C-15 in the D-ring to give 3, 4-dihydroxy-3, 4, 15, 16-tetrahydro-11-trifluoromethyl-cyclopenta[a]phenanthren-17-one as the only mutagenic metabolite. In these respects its behaviour is closely similar to that of the 11-methyl compound, suggesting that the electronic nature of the bay-region substituent is rather less critical than its spatial configuration in influencing metabolism to genotoxic intermediates. It remains to be seen, however, whether the trifluoromethyl compound is also a carcinogen.
Original languageEnglish
Pages (from-to)1697-1699
JournalCarcinogenesis
Volume14
Issue number8
DOIs
Publication statusPublished - Aug 1993
Externally publishedYes

    Fingerprint

Cite this